Tumor necrosis factor blockers and reactivation of latent tuberculosis

被引：41

作者：

Keane, J

机构：

[1] St James Hosp, CResT, Dublin 8, Ireland

[2] Trinity Coll Dublin, Trinity Ctr Hlth Sci, Inst Mol Med, Dublin, Ireland

来源：

CLINICAL INFECTIOUS DISEASES | 2004年 / 39卷 / 03期

关键词：

D O I：

10.1086/421499

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

引用

收藏

页码：300 / 302

页数：3

相关论文

共 10 条

[1]

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report [J].

Gómez-Reino, JJ ;

Carmona, L ;

Valverde, VR ;

Mola, EM ;

Montero, MD .

ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2122-2127

[2]

Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[3]

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway [J].

Lügering, A ;

Schmidt, M ;

Lügering, N ;

Pauels, HG ;

Domschke, W ;

Kucharzik, T .

GASTROENTEROLOGY, 2001, 121 (05) :1145-1157

[4]

Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor [J].

Mohan, AK ;

Coté, TR ;

Block, JA ;

Manadan, AM ;

Siegel, JN ;

Braun, MM .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (03) :295-299

[5]

Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy -: Association with decreased interferon-γ production and toll-like receptor 4 expression [J].

Netea, MG ;

Radstake, T ;

Joosten, LA ;

van der Meer, JWM ;

Barrera, P ;

Kullberg, BJ .

ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1853-1857

[6]

Binding and functional comparisons of two types of tumor necrosis factor antagonists [J].

Scallon, B ;

Cai, A ;

Solowski, N ;

Rosenberg, A ;

Song, XY ;

Shealy, D ;

Wagner, C .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02) :418-426

[7]

Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy [J].

Taylor, JC ;

Orkin, R ;

Lanham, J .

RHEUMATOLOGY, 2003, 42 (07) :901-902

[8]

Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy [J].

Wolfe, F ;

Michaud, K ;

Anderson, J ;

Urbansky, K .

ARTHRITIS AND RHEUMATISM, 2004, 50 (02) :372-379

[9]

TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection [J].

Zganiacz, A ;

Santosuosso, M ;

Wang, J ;

Yang, T ;

Chen, LH ;

Anzulovic, M ;

Alexander, S ;

Gicquel, B ;

Wan, YH ;

Bramson, J ;

Inman, M ;

Xing, Z .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) :401-413

[10]

Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab [J].

Zou, JX ;

Rudwaleit, M ;

Brandt, J ;

Thiel, A ;

Braun, J ;

Sieper, J .

ARTHRITIS AND RHEUMATISM, 2003, 48 (03) :780-790